Rankings
▼
Calendar
FOLD Q2 2023 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$95M
+17.1% YoY
Gross Profit
$85M
90.4% margin
Operating Income
-$19M
-20.0% margin
Net Income
-$43M
-45.7% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
+9.5%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$18M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$730M
Total Liabilities
$619M
Stockholders' Equity
$112M
Cash & Equivalents
$211M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$95M
$81M
+17.1%
Gross Profit
$85M
$73M
+17.7%
Operating Income
-$19M
-$61M
+68.9%
Net Income
-$43M
-$62M
+30.4%
Geographic Segments
Non-US
$57M
61%
UNITED STATES
$37M
39%
← FY 2023
All Quarters
Q3 2023 →